With Evo 2, researchers can rapidly predict protein structures and generate DNA sequences, significantly advancing the fields ...
PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological ...